{{item}}
无血清间充质干细胞培养基是为正常人类间充质干细胞体外培养设计的适于其生长的完全培养基。是经灭菌的液体培养基,包含必需和非必需氨基酸、维生素、有机和无机化合物、激素、生长因子和微量矿物质。该培养基不含血清。该培养基含HEPES和碳酸氢盐缓冲体系,在5%二氧化碳/95%空气培养箱中平衡时PH值为7.4。该培养基在数量上和质量上都保证理想的营养平衡状态,选择性促进体外正常人类间充质干细胞的生长。
无血清间充质干细胞培养基包含500ml基础培养基,5m无血清间充质干细胞生长因子(MSCGS,目录编号7562)和5ml青霉素/链霉素溶液(P/S,目录编号0503)。
无血清间充质干细胞培养基包含500ml基础培养基,5m无血清间充质干细胞生长因子(MSCGS,目录编号7562)和5ml青霉素/链霉素溶液(P/S,目录编号0503)。
货号 | 7511 |
产地 | 美国 |
缩写 | MSCM-sf |
规格 | 500ml |
用途 | 科研 |
储存 | 4度,-20度 |
运输 | 胶冰 |
1.) Friedman E. (2013) "Mirk/dyrk1B kinase in ovarian cancer." Int J Mol Sci. 14: 5560
2.) Cha Y, Kim DK, Hyun J, Kim SJ, Park KS. (2013) " TCEA3 binds to TGF-beta receptor I and induces Smad-independent, JNK-dependent apoptosis in ovarian cancer cells." Cellular Signal. 25: 1245-51.
3.) Takahashi Y, Koyanagi T, Suzuki Y, Saga Y, Kanomata N, Moriya T, Suzuki M, Sato Y. (2012) "Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis." Mol Cancer Res. 10: 1135-46.
4.) Semaan A, Qazi AM, Seward S, Chamala S, Bryant CS, Kumar S, Morris R, Steffes CP, Bouwman DL, Mukarah AR, Weaver DW, Gruber SA, Batchu RB. (2011) "MicroRNA-101 Inhibits Growth of Epithelial Ovarian Cancer by Relieving Chromatin-Mediated Transcriptional Repression of p21waf1/cip1." Pharm Res. 28: 3079-90.
5.) Guo AM, Liu X, Al-Wahab Z, Maddippati KR, Ali-Fehmi R, Scicli AG, Munkarah AR. (2011) "Role of 12-lipoxygenase in regulation of ovarian cancer cell proliferation and survival." Cancer ChemotherPharmacol.68: 1273-83.
6.) Selvendiran K, Ahmed S, Dayton A, Kuppusamy ML, Tazi M, Bratasz A, Tong L, Rivera BK, Kalai T, Hideg K, Kuppusamy P. (2010) "Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenylpiperidones: differential cytotoxicity in healthy and cancer cells." Free RadicBiol Med.48: 1228-35.
2.) Cha Y, Kim DK, Hyun J, Kim SJ, Park KS. (2013) " TCEA3 binds to TGF-beta receptor I and induces Smad-independent, JNK-dependent apoptosis in ovarian cancer cells." Cellular Signal. 25: 1245-51.
3.) Takahashi Y, Koyanagi T, Suzuki Y, Saga Y, Kanomata N, Moriya T, Suzuki M, Sato Y. (2012) "Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis." Mol Cancer Res. 10: 1135-46.
4.) Semaan A, Qazi AM, Seward S, Chamala S, Bryant CS, Kumar S, Morris R, Steffes CP, Bouwman DL, Mukarah AR, Weaver DW, Gruber SA, Batchu RB. (2011) "MicroRNA-101 Inhibits Growth of Epithelial Ovarian Cancer by Relieving Chromatin-Mediated Transcriptional Repression of p21waf1/cip1." Pharm Res. 28: 3079-90.
5.) Guo AM, Liu X, Al-Wahab Z, Maddippati KR, Ali-Fehmi R, Scicli AG, Munkarah AR. (2011) "Role of 12-lipoxygenase in regulation of ovarian cancer cell proliferation and survival." Cancer ChemotherPharmacol.68: 1273-83.
6.) Selvendiran K, Ahmed S, Dayton A, Kuppusamy ML, Tazi M, Bratasz A, Tong L, Rivera BK, Kalai T, Hideg K, Kuppusamy P. (2010) "Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenylpiperidones: differential cytotoxicity in healthy and cancer cells." Free RadicBiol Med.48: 1228-35.
There are no product questions yet.
特殊培养基
特殊培养基